ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,915
0,34%
Bitcoin
59 366,24
0,41%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. IQVIA Holdings Inc (IQV)

  7. IQVIA Holdings Inc (IQV) Actualités

IQV IQVIA Holdings Inc

222,14
-10,80 (-4,64%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
IQVIA Holdings Inc IQV NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-10,80 -4,64% 222,14 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
231,80 221,33 232,88 222,14 232,94
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202413:00BWIQVIA Reports First-Quarter 2024 Results
15/4/202422:15BWIQVIA to Announce First-Quarter 2024 Results on May 2, 2024
08/4/202422:01BWIQVIA and Salesforce Expand Global Partnership to Accelerate..
06/3/202422:15BWIQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global..
02/3/202401:49EDGAR2Form 144 - Report of proposed sale of securities
26/2/202414:00BWIQVIA Publishes its 2023 Environmental, Social and..
23/2/202422:17EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/2/202415:00BWGlobal Biopharma R&D Boasts Increased Funding, Productivity..
21/2/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:15BWIQVIA CFO Ron Bruehlman to Speak at Citi’s Unplugged Medtech..
16/2/202423:20EDGAR2Form 144 - Report of proposed sale of securities
14/2/202413:05EDGAR2Form 8-K - Current report
14/2/202413:00BWIQVIA Reports Fourth-Quarter and Full-Year 2023 Results;..
13/2/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202423:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202423:15EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
06/2/202415:00BWIQVIA Named to Fortune® World's Most Admired Companies™..
24/1/202422:15BWIQVIA to Announce Fourth-Quarter and Full-Year 2023 Results..
17/1/202412:00BWGlobal Medicine Spending to Reach $2.3 Trillion by 2028 as..
03/1/202411:41IHMARKETNEWSWall Street Highlights: Tesla’s Competition with BYD,..
29/11/202314:30BWIQVIA Digital Enablement Named PM360 Trailblazer 2023..
28/11/202322:19EDGAR2Form 8-K - Current report
21/11/202322:15BWIQVIA CFO Ron Bruehlman to Speak at Evercore HealthCONx..
17/11/202315:23BWIQVIA Announces Upsizing of its Allocation of New Term B..
15/11/202315:28EDGAR2Form 8-K - Current report
15/11/202315:11BWIQVIA Announces Pricing of Upsized Offering of Senior..
14/11/202315:07BWIQVIA Announces Offering of Senior Secured Notes
06/11/202314:00BWIQVIA’s Christina Mack Named 2023 PharmaVoice 100 Honoree
01/11/202321:29EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202312:05EDGAR2Form 8-K - Current report
01/11/202312:00BWIQVIA Reports Third-Quarter 2023 Results
23/10/202314:00BWIQVIA to Provide Sanofi Its Orchestrated Customer Engagement..
11/10/202313:30BWIQVIA and CEPI Collaborate to Strengthen Global Research..
10/10/202313:02IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Recommendations
09/10/202322:15BWIQVIA to Announce Third-Quarter 2023 Results on November 1,..
05/10/202314:00BWPatient Organizations Gave $22 Billion in Grants for..
03/10/202314:00BWIQVIA Builds on its Strategic Collaboration with argenx to..
26/9/202323:17EDGAR2Form 8-K - Current report
26/9/202302:01BWIQVIA Appoints Richard Staub III President of Research &..
21/9/202323:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202322:10EDGAR2Form 144 - Report of proposed sale of securities
12/9/202314:30BWIQVIA Named a Leader in Pharmacovigilance Solutions in IDC..
05/9/202314:30BWIQVIA CFO Ron Bruehlman to Speak at Baird Global Healthcare..
01/9/202314:30BWIQVIA CEO Ari Bousbib to Speak at Morgan Stanley Annual..
07/8/202323:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202322:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Dernières Valeurs Consultées

NYSE
IQV
IQVIA
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés